User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Glibenclamide impairment of B-cell function involves alterations of cytoplasmic Ca2+ regulation

Primary tabs

download
  • Open access
  • PDF
  • 3.48 M
Anello, Marcello Gilon, Patrick [UCL] Henquin, Jean-Claude [UCL]

Chronic treatment with glibenclamide alters the cell response to various insulin secretagogues. The possible mechanisms have been studied with islets cultured for ISh in the presence of 10 mmo1/! glucose, with (test) or without (control) a therapeutical concentration of glibenclamide (10 nmol/l) […]

Document type Communication à un colloque (Conference Paper) – Présentation orale avec comité de sélection, Abstract
Access type Accès libre
Publication date 1998
Language Anglais
Conference "34th Annual Meeting of the European Association for the Study of Diabetes (EASD)", (Spain) Barcelona (du 08/09/1998 au 12/09/1998)
Journal information "Diabetologia" - Vol. 41, no.Suppl 1, p. A141 (1998)
Peer reviewed yes
issn 0012-186X
e-issn 1432-0428
Publisher Springer ((Germany) Heidelberg )
Publication status Publié
Affiliation UCL - MD/FSIO - Département de physiologie et pharmacologie
Links
Bibliographic reference Anello, Marcello ; Gilon, Patrick ; Henquin, Jean-Claude. Glibenclamide impairment of B-cell function involves alterations of cytoplasmic Ca2+ regulation.34th Annual Meeting of the European Association for the Study of Diabetes (EASD) ((Spain) Barcelona, du 08/09/1998 au 12/09/1998). In: Diabetologia, Vol. 41, no.Suppl 1, p. A141 (1998)
Permanent URL http://hdl.handle.net/2078.1/230764